Skip to content
Home/Companies/Biotech/NetZeroNitrogen

NetZeroNitrogen

Biotech·United Kingdom·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns NetZeroNitrogen?

NetZeroNitrogen is a British Biotech company, currently owned by Revent since 2023.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
Revent
Investor
Revent
Revent Fund I · 2021 · VC

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive

More from Revent Fund I

Other portfolio companies in the same fund.

Farmless
Farmless
Active
FoodTechNetherlands· 2023
Magnotherm
Magnotherm
Active
ClimateTechGermany· 2023
Resourcify
Active
SoftwareGermany· 2023
Apiday
Apiday
Active
SaaSFrance· 2022
Granular Energy
Granular Energy
Active
ClimateTechFrance· 2022
Noscendo
Exited 2026
MedTechGermany· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns NetZeroNitrogen?

NetZeroNitrogen is currently owned by Revent, through Revent Fund I, since 2023.

When did Revent acquire NetZeroNitrogen?

Revent acquired NetZeroNitrogen in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue